Synthesis, characterization and biological evaluation of novel octahedral Ru(III) complexes containing pentadentate Schiff base ligands

Autor: Suad A.M. Moubeen, Mohamed F. El-Shahat, Ayman A. Abdel Aziz, Attia S. Attia
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Current Chemistry Letters, Vol 10, Iss 1, Pp 17-32 (2021)
Druh dokumentu: article
ISSN: 1927-7296
1927-730X
DOI: 10.5267/j.ccl.2020.7.001
Popis: New series of mononuclear octahedral Ru(III) complexes of general formula [RuL1-3Cl]Cl2 (1-3) where L = dianion of Schiff bases namely: 2,2'-(((1E,1'E)-thiophene-2,5-diylbis(methaneylylidene))bis(azaneylylidene))diphenol (H2L1), 2,2'-(((1E,1'E)-thiophene-2,5-diylbis(methaneylylidene))bis(azaneylylidene))dibenzenethiol (H2L2) and 2,2'-(((1E,1'E)-thiophene-2,5-diylbis(methaneylyli-dene))bis(azaneylyli-dene))-dibenzoic acid (H2L3), respectively are synthesized and characterized by different physico-chemical techniques. The results of interaction of complexes with CT-DNA supported that, the Ru (III) complexes bind to DNA via an intercalative mode. The interaction has also been investigated by gel electrophoresis. Interestingly, it was found that all Ru(III) complexes cleave super coiled (SC) pUC19 plasmid DNA efficiently in the absence of an external agent. Further, the antiproliferative activity of the complexes on Human Cervical Cancer Cells (HeLa) and Human Breast Cancer Cells (MCF-7) were evaluated by MTT assay, which revealed that, all the complexes showed more intense inhibition against HeLa and MCF-7 cell lines, particularly Ru(III) complex (3) attenuated the strongest proliferation, allowing its use as chemotherapeutic agent for cancer treatment.
Databáze: Directory of Open Access Journals